DigestRedComo funciona
Red
/
Empresas
Ve
No verificado

Vertex Pharmaceuticals Incorporated

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

69 Comunicados de prensa

Ver todos los comunicados de prensa
11/06/2026
Industria
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
05/06/2026
Eventos
Industria
Biotecnología
Farmacéutica
Sanidad
Salud
Infancia
Ir de compras
Medicina - Varios
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
03/06/2026
Eventos
Web y redes sociales
Asociaciones/Profesionales
Salud
Finanzas
Medicina - Varios
Farmacéutica
Biotecnología
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
01/06/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
11/05/2026
Eventos
Biotecnología
Finanzas
Salud
Asociaciones/Profesionales
Farmacéutica
Vertex to Participate in Upcoming May Investor Conferences
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
06/05/2026
Industria
Salud
Biotecnología
Sanidad
Farmacéutica
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
04/05/2026
Mercado de valores
Web y redes sociales
Telefonía
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Vertex Reports First Quarter 2026 Financial Results
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
06/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Vertex to Announce First Quarter 2026 Financial Results on May 4th
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
01/04/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Sanidad
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0
09/03/2026
Multimedia
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
Fuente
Vertex Pharmaceuticals Incorporated
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0